Skip to main content

Country stakeholder interview reports on DMPA-SC self-injection

Prior to implementing the first DMPA-SC self-injection studies in sub-Saharan Africa, PATH led in-depth interviews with key family planning stakeholders in Burkina Faso, Niger, Senegal, and Uganda in 2014 to 2016. Conducted in partnership with UNFPA in Niger and Burkina Faso, these interviews covered perceived benefits, challenges, and research needs for self-injection.

Institutional Author(s): PATH
Publication date: 2017